Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
|Study Number||Lead Group||Study Title||CIRB||Study Status|
|WF-1805CD||NCORP-Wake Forest University||Implementation and Effectiveness Trial of HN-STAR||Cancer Prevention and Control CIRB||Available to Open|
|NWU2015-06-02||CLO-Northwestern University||Immunogenicity of Nonavalent HPV Vaccine Administered Prior To Living Donor Renal Transplantation in Adult Women: A Prospective, Single-Arm, Multi-Center Clinical Trial||Cancer Prevention and Control CIRB||Available to Open|
|UWI2016-07-01||CLO-University of Wisconsin||Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus met® XR in Subjects with Stage I-IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Prior to Definitive Treatment||Cancer Prevention and Control CIRB||Available to Open|
|URCC-19085||NCORP-University of Rochester Cancer Center||Wireless Transcutaneous Electrical Nerve Stimulation (TENS) For Chemotherapy-Induced Peripheral Neuropathy: A Phase II Clinical Trial||Cancer Prevention and Control CIRB||Available to Open|
|A221701||Alliance||Phase III Placebo-Controlled Trial to Evaluate Dexamethasone Use for Everolimus-Induced Oral Stomatitis: Prevention Versus Early Treatment Approaches||Cancer Prevention and Control CIRB||Available to Open|
|UWI2014-03-01||CLO-University of Wisconsin||A Phase I Trial of the Safety and Immunogenicity of a DNA Plasmid Based Vaccine (WOKVAC) Encoding Epitopes Derived from Three Breast Cancer Antigens (IGFBP-2, HER2, AND IGF-1R) in Patients with Breast Cancer||Cancer Prevention and Control CIRB||Available to Open|
|WF-97116||NCORP-Wake Forest University||A Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil in Chemotherapy Exposed Breast Cancer Survivors with Cognitive Impairment||Cancer Prevention and Control CIRB||Available to Open|
|URCC-18004CD||NCORP-University of Rochester Cancer Center||Understanding the Impact of Drug Shortages on Oncology Care Delivery||Cancer Prevention and Control CIRB||Completed|
|MDA2014-04-02||CLO-MD Anderson||VADIS Trial: Phase II trial of Nelipepimut-S Peptide Vaccine in Women with DCIS of the Breast||Cancer Prevention and Control CIRB||Available to Open|
|WF-1806||NCORP-Wake Forest University||Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study||Cancer Prevention and Control CIRB||Available to Open|